1. Antibiotic resistance heterogeneity and LasR diversity within Pseudomonas aeruginosa populations from pneumonia in intensive care unit patients.
- Author
-
Crémet L, Leroy AG, Muller D, Delanou S, Burghelea A, Broquet A, Roquilly A, and Caroff N
- Subjects
- Bacterial Proteins metabolism, Bronchoalveolar Lavage, Ceftazidime pharmacology, DNA, Bacterial, Genetic Variation, Humans, Imipenem pharmacology, Intensive Care Units, Microbial Sensitivity Tests, Mutation, Quorum Sensing, Trans-Activators metabolism, beta-Lactams pharmacology, Anti-Bacterial Agents pharmacology, Bacterial Proteins genetics, Drug Resistance, Bacterial, Pneumonia microbiology, Pseudomonas Infections microbiology, Pseudomonas aeruginosa drug effects, Pseudomonas aeruginosa genetics, Trans-Activators genetics
- Abstract
This study investigated within-host heterogeneity of 66 Pseudomonas aeruginosa populations from pneumonia in 51 critically ill ventilated patients by examining 30 colonies per bronchoalveolar lavage (BAL). Differences in antibiotic susceptibility and quorum-sensing (QS) phenotypes were observed between the members of 14 (21.2%) and 10 (15.2%) populations, respectively. A significant association was found between QS deficiency and ceftazidime resistance. QS deficiency was associated with various lasR modifications, and was observed in 25 of 51 (49.0%) patients, including seven patients who received ≤48 h of ventilation. This study confirms the need to examine diverse colonies when analysing BAL cultures, particularly in β-lactam-exposed patients, to avoid missing ceftazidime- or imipenem-resistant isolates., (Copyright © 2021 Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF